A national digital molecular pathology research programme led by the Belfast Cancer Research UK (CRUK) Center has been awarded the highly competitive CRUK Accelerator Award. Using PathXL software, this programme will link a number of major UK...

PathXL today announced the publication of research demonstrating that TissueMark, the company's automated tumor analysis platform, can bring reproducibility and accuracy to molecular diagnostics in lung cancer. The results come from a...

'High quality training relies on expert trainers as well as access to a comprehensive, validated set of microscope slides. Availability of both of these is limited.' For this reason Intellectual Ventures Laboratory (IV Lab) and Global Good...

Thurs, 4th June  | UK 4pm BST | EU 5pm CEST | USA 11am EST, 10am CDT |              Register here Join our guest speaker Professor Manuel Salto-Tellez, Clinical Professor at Queen’s University, Belfast as he...

PathXL, a global pioneer in the use of web-based solutions for digital pathology, announced the success of their first user group meeting. Approved by The Royal College of Pathologists for CPD credits, the main focus of the 2 day conference was...

In December 2014 PathXL announced a significant upgrade to its award-winning automated tumor annotation and analysis software, TissueMark®. Owing to the overwhelming success of the initial announcement, PathXL plan to unveil and demonstrate...